Literature DB >> 1639612

Immune response to Staphylococcus epidermidis-induced endophthalmitis in a rabbit model.

U Pleyer1, B J Mondino, S A Adamu, H Pitchekian-Halabi, R E Engstrom, B J Glasgow.   

Abstract

Although Staphylococcus epidermidis is the most common cause of postoperative pseudophakic endophthalmitis, little is known about the immune response to S. epidermidis-induced endophthalmitis. Using a rabbit model, the immune response to an intravitreal injection of 7000 S. epidermidis (group 1) or 30,000 S. epidermidis (group 2) organisms was investigated. Clinical evaluations showed that rabbits in group 2 had a more severe inflammatory reaction in the conjunctiva, cornea, iris, and vitreous than those in group 1. The inflammatory reaction in group 1 largely resolved by day 30; group 2 continued to show a severe inflammatory response. Histopathologic findings correlated with clinical findings, with rabbits in group 2 showing a more severe inflammatory reaction in both the anterior and posterior segments of the globe. Positive vitreous cultures for S. epidermidis were present in rabbits in group 1 on days 3, 7, 10, 14, and 21 but not thereafter. However, group 2 had higher vitreous colony counts at days 3, 7, and 14 and negative vitreous cultures thereafter. Neither group showed delayed hypersensitivity to S. epidermidis antigens (evaluated by skin tests). Serum immunoglobulin (Ig) G antibody levels to phenol-inactivated S. epidermidis and glycerol teichoic acid (GTA) increased progressively, reached a peak at days 10-14, and then declined in both groups. Serum IgA antibody levels to these antigens were not detected. Group 2 had a more prolonged IgG antibody response in vitreous and aqueous than group 1. Tear fluid showed the weakest IgG and IgA antibody response to S. epidermidis and GTA. S. epidermidis-induced endophthalmitis was associated with a humoral but not a delayed hypersensitivity response to this organism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639612

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  [Diagnostics and differential diagnosis of acute retinal necrosis].

Authors:  U Pleyer; S Metzner; J Hofmann
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

2.  [Rational antibiotic therapy in ophthalmology].

Authors:  W Behrens-Baumann; U Frank; T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

Review 3.  [Therapy and prognosis of bacterial keratitis].

Authors:  W Behrens-Baumann; U Pleyer
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

4.  [Adjunctive corticosteroids for antimicrobial treatment].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

Review 5.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  [Prophylaxis and therapy of postoperative endophthalmitis. Criticism of the ESCRS study and the Early Vitrectomy study].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

7.  Effect of anterior chamber air bubble on prevention of experimental Staphylococcus epidermidis endophthalmitis.

Authors:  Morteza Mehdizadeh; Feisal Rahat; Mohammad Reza Khalili; Farzin Ahmadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-12       Impact factor: 3.117

8.  Intravitreal Infliximab Injection to Treat Experimental Endophthalmitis.

Authors:  Osman Ondas; Orhan Ates; Sadullah Keles; Kenan Yildirim; Orhan Baykal; Selina Aksak Karamese; Murat Karamese; Hakan Uslu; Mustafa Yildirim; Muhammet Emin Naldan; Irem Ates
Journal:  Eurasian J Med       Date:  2017-06-05

9.  Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis.

Authors:  Mary E Marquart; Angela H Benton; Regina C Galloway; Lisa M Stempak
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

10.  Comparison of efficiency of intravitreal ceftazidime and intravitreal cefepime in the treatment of experimental Pseudomonas aeruginosa endophthalmitis.

Authors:  Nurettin Deniz; Orhan Aydemir; Mete Güler; Nusret Akpolat; Ahmet Kizirgil
Journal:  Indian J Ophthalmol       Date:  2013-09       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.